Alzheimer's and Parkinson's Disease Novel Therapeutic Target: The Mitochondrial Pyruvate Carrier - Ligand Docking to Screen Natural Compounds Related to Classic Inhibitors

Publisher： IGI Global_journal

E-ISSN： 1947-9123|7|2|68-82

ISSN： 1947-9115

Source： International Journal of Knowledge Discovery in Bioinformatics (IJKDB), Vol.7, Iss.2, 2017-07, pp. : 68-82

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Restoring impaired protein metabolism in Parkinson's disease — TFEB‐mediated autophagy as a novel therapeutic target

By  

MOVEMENT DISORDERS, Vol. 28, Iss. 10, 2013-09 ,pp. : 1346-1346

John Wiley & Sons Inc

Access to resources Recommend Favorite

CNTF: a target therapeutic for obesity-related metabolic disease?

By Matthews Vance   Febbraio Mark  

Journal of Molecular Medicine, Vol. 86, Iss. 4, 2008-04 ,pp. : 353-361

Springer Publishing Company

Access to resources Recommend Favorite

Therapeutic prospects for Parkinson disease

By  

ANNALS OF NEUROLOGY, Vol. 74, Iss. 3, 2013-09 ,pp. : 337-347

John Wiley & Sons Inc

Access to resources Recommend Favorite

Alzheimer’’s disease: from pathogenesis to novel therapeutic approaches

By Scarpini Elio   Galimberti Daniela  

Therapy, Vol. 6, Iss. 2, 2009-03 ,pp. : 259-277

Future Medicine

Access to resources Recommend Favorite

The vasculature in Alzheimer''s disease: a new therapeutic target for an old disease?

By Grammas Paula  

Therapy, Vol. 8, Iss. 5, 2011-09 ,pp. : 463-465

Future Medicine

Access to resources Recommend Favorite